Streetbeat News

Price Targets

EAT

JP Morgan analyst John Pitzer maintains an Overweight rating on Brinker International (NYSE:EAT) but lowers the price target from $42 to $40.

Portfolio Pulse from richadhand@benzinga.com

August 17, 2023 | 2:50 pm

BBIO

JP Morgan analyst Anupam Rama maintains an Overweight rating on BridgeBio Pharma (NASDAQ:BBIO) but lowers the price target from $42 to $38.

Portfolio Pulse from richadhand@benzinga.com

August 17, 2023 | 2:49 pm

TJX

JP Morgan analyst Matthew Boss maintains an Overweight rating on TJX Companies and raises the price target from $104 to $105.

Portfolio Pulse from richadhand@benzinga.com

August 17, 2023 | 2:45 pm

TGT

JP Morgan analyst Christopher Horvers maintains a Neutral rating on Target (NYSE:TGT) and raises the price target from $115 to $120.

Portfolio Pulse from richadhand@benzinga.com

August 17, 2023 | 2:44 pm

PAYX

TD Cowen analyst Bryan Bergin maintains an Outperform rating on Paychex (NASDAQ:PAYX) and raises the price target from $123 to $130.

Portfolio Pulse from Benzinga Newsdesk

August 17, 2023 | 2:43 pm

SNPS

JP Morgan analyst Jackson Ader maintains an Overweight rating on Synopsys (NASDAQ:SNPS) and raises the price target from $470 to $500.

Portfolio Pulse from richadhand@benzinga.com

August 17, 2023 | 2:43 pm

TGT

TD Cowen analyst Oliver Chen has maintained an 'Outperform' rating on Target (NYSE:TGT) but lowered the price target from $165 to $161.

Portfolio Pulse from Benzinga Newsdesk

August 17, 2023 | 2:39 pm

SCCO

JP Morgan analyst Rodolfo Angele maintains an Underweight rating on Southern Copper (NYSE:SCCO) and raises the price target from $52.5 to $55.5.

Portfolio Pulse from richadhand@benzinga.com

August 17, 2023 | 2:34 pm

PEG

JP Morgan analyst Jeremy Tonet maintains an Overweight rating on Public Service Enterprise (NYSE:PEG) and raises the price target from $68 to $70.

Portfolio Pulse from richadhand@benzinga.com

August 17, 2023 | 2:32 pm

IDYA

JP Morgan analyst Anupam Rama maintains an Overweight rating on IDEAYA Biosciences (NASDAQ:IDYA) and raises the price target from $28 to $32.

Portfolio Pulse from richadhand@benzinga.com

August 17, 2023 | 2:31 pm